TREM-1 inhibitory peptide GF9

GF9 (Human TREM-1 (213-221) ), a TREM-1 inhibitory peptide, effectively mitigates the severe inflammation associated with rheumatoid arthritis (RA) [1]. This nonapeptide functions independently of ligands to inhibit TREM-1.

[C@H](CC1=CC=CC=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(O)=O)=O)[C@@H](C)C)=O)CC(C)C)=O)CO)=O)CCCCN)=O)CO)=O)CC(C)C)=O)NC(CN)=O